Deglycosylated bleomycin induces apoptosis in lymphoma cell via c-jun NH2-terminal kinase but not reactive oxygen species-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Deglycosylated bleomycin induces apoptosis in lymphoma cell via c-jun NH2-terminal kinase but not reactive oxygen species

Published:2007-11 Issue:10 Volume:74 Page:1445-1455
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Souhir Brahim,Laurent Prévotat,Sonia Yatouji,Delphine Mérino,Marion Cortier,Cédric Rébé,Olivier Micheau,Abderraouf Kenani,Ali Bettaieb

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference49 articles.

1. New antibiotics, bleomycin A and B;Umezawa;J Antibiot (Tokyo),1966

2. Bleomycins: towards better therapeutics;Chen;Nat Rev Cancer,2005

3. Minimal bone marrow damage in mice given bleomycin;Boggs;Cancer Res,1974

4. The effects of bleomycin on immunocompetence in man;Lehane;Cancer Res,1975

5. Bleomycin in non-Hodgkin's lymphoma;Bayer;Semin Oncol,1992

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JNK signaling as a target for anticancer therapy;Pharmacological Reports;2021-03-12

2. The combination of Bleomycin with TRAIL agonists or PKC inhibitors sensitizes solid tumor cells to BLM-mediated apoptosis: new strategies to overcome chemotherapy resistance of tumors;Medicinal Chemistry Research;2017-05-19

3. Deglycobleomycin A6 analogues modified in the methylvalerate moiety;Bioorganic & Medicinal Chemistry;2011-06

4. Dérivé de la bléomycine générant moins de ROS ? Moins de fibrose ? Une alternative dans le développement d’une thérapie anticancéreuse efficace mais moins toxique;Bulletin du Cancer;2010-05

5. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231;Cancer Letters;2009-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3